Davita Healthcare Partners Stock Price Prediction
| DVA Stock | USD 165.63 2.33 1.39% |
Oversold Vs Overbought
50
Oversold | Overbought |
Quarterly Earnings Growth (0.05) | EPS Estimate Next Quarter 2.28 | EPS Estimate Current Year 9.7362 | EPS Estimate Next Year 11.3886 | Wall Street Target Price 156.9022 |
Using DaVita HealthCare hype-based prediction, you can estimate the value of DaVita HealthCare Partners from the perspective of DaVita HealthCare response to recently generated media hype and the effects of current headlines on its competitors.
DaVita HealthCare Hype to Price Pattern
Investor biases related to DaVita HealthCare's public news can be used to forecast risks associated with an investment in DaVita. The trend in average sentiment can be used to explain how an investor holding DaVita can time the market purely based on public headlines and social activities around DaVita HealthCare Partners. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of DaVita HealthCare's market sentiment to its price can help taders to make decisions based on the overall investors consensus about DaVita HealthCare.
The fear of missing out, i.e., FOMO, can cause potential investors in DaVita HealthCare to buy its stock at a price that has no basis in reality. In that case, they are not buying DaVita because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
DaVita HealthCare after-hype prediction price | USD 165.63 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
DaVita |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of DaVita HealthCare's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
DaVita HealthCare After-Hype Price Prediction Density Analysis
As far as predicting the price of DaVita HealthCare at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in DaVita HealthCare or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of DaVita HealthCare, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
DaVita HealthCare Estimiated After-Hype Price Volatility
In the context of predicting DaVita HealthCare's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on DaVita HealthCare's historical news coverage. DaVita HealthCare's after-hype downside and upside margins for the prediction period are 163.57 and 167.69, respectively. We have considered DaVita HealthCare's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
DaVita HealthCare is very steady at this time. Analysis and calculation of next after-hype price of DaVita HealthCare is based on 3 months time horizon.
DaVita HealthCare Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as DaVita HealthCare is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading DaVita HealthCare backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with DaVita HealthCare, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.16 | 2.08 | 0.81 | 0.22 | 9 Events / Month | 10 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
165.63 | 165.63 | 0.00 |
|
DaVita HealthCare Hype Timeline
On the 29th of November DaVita HealthCare is traded for 165.63. The entity has historical hype elasticity of 0.81, and average elasticity to hype of competition of -0.22. DaVita is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is about 41.03%. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is currently at 0.16%. %. The volatility of related hype on DaVita HealthCare is about 149.31%, with the expected price after the next announcement by competition of 165.41. About 49.0% of the company shares are held by company insiders. The company has Price/Earnings To Growth (PEG) ratio of 1.25. DaVita HealthCare recorded earning per share (EPS) of 9.28. The entity had not issued any dividends in recent years. The firm had 2:1 split on the 9th of September 2013. Considering the 90-day investment horizon the next anticipated press release will be in about 9 days. Check out DaVita HealthCare Basic Forecasting Models to cross-verify your projections.DaVita HealthCare Related Hype Analysis
Having access to credible news sources related to DaVita HealthCare's direct competition is more important than ever and may enhance your ability to predict DaVita HealthCare's future price movements. Getting to know how DaVita HealthCare's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how DaVita HealthCare may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| SGRY | Surgery Partners | 1.50 | 9 per month | 0.00 | (0.20) | 3.72 | (4.88) | 17.97 | |
| ACHC | Acadia Healthcare | (0.19) | 7 per month | 0.00 | (0.26) | 3.36 | (5.78) | 21.88 | |
| ENSG | The Ensign Group | (13.99) | 10 per month | 0.00 | (0.09) | 2.32 | (2.11) | 10.08 | |
| FSNUY | Fresenius SE Co | 0.00 | 0 per month | 0.00 | (0.16) | 1.88 | (1.95) | 5.02 | |
| THC | Tenet Healthcare | (1.21) | 9 per month | 0.00 | (0.09) | 3.81 | (4.49) | 21.18 | |
| HCA | HCA Holdings | (1.10) | 10 per month | 0.00 | (0.22) | 2.06 | (2.82) | 11.25 | |
| USPH | US Physicalrapy | (0.44) | 9 per month | 1.23 | 0.06 | 3.06 | (2.56) | 20.31 | |
| AMED | Amedisys | 0.77 | 9 per month | 0.00 | (0.31) | 0.61 | (0.93) | 5.99 | |
| OPCH | Option Care Health | (0.98) | 8 per month | 0.00 | (0.14) | 2.91 | (3.57) | 26.20 | |
| EHC | Encompass Health Corp | 1.23 | 11 per month | 0.84 | 0.05 | 1.74 | (1.86) | 9.75 | |
| UHS | Universal Health Services | 3.20 | 12 per month | 0.00 | (0.16) | 2.40 | (4.07) | 14.88 | |
| AMN | AMN Healthcare Services | (7.20) | 10 per month | 0.00 | (0.21) | 4.43 | (5.71) | 36.93 | |
| CYH | Community Health Systems | 0.30 | 10 per month | 0.00 | (0.17) | 5.03 | (6.25) | 28.67 |
DaVita HealthCare Additional Predictive Modules
Most predictive techniques to examine DaVita price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for DaVita using various technical indicators. When you analyze DaVita charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About DaVita HealthCare Predictive Indicators
The successful prediction of DaVita HealthCare stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as DaVita HealthCare Partners, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of DaVita HealthCare based on analysis of DaVita HealthCare hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to DaVita HealthCare's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to DaVita HealthCare's related companies. | 2023 | 2024 (projected) | Dividend Yield | 0.0136 | 0.0129 | Price To Sales Ratio | 0.78 | 0.74 |
Story Coverage note for DaVita HealthCare
The number of cover stories for DaVita HealthCare depends on current market conditions and DaVita HealthCare's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that DaVita HealthCare is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about DaVita HealthCare's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
DaVita HealthCare Short Properties
DaVita HealthCare's future price predictability will typically decrease when DaVita HealthCare's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of DaVita HealthCare Partners often depends not only on the future outlook of the potential DaVita HealthCare's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. DaVita HealthCare's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 93.2 M | |
| Cash And Short Term Investments | 391.7 M |
Complementary Tools for DaVita Stock analysis
When running DaVita HealthCare's price analysis, check to measure DaVita HealthCare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DaVita HealthCare is operating at the current time. Most of DaVita HealthCare's value examination focuses on studying past and present price action to predict the probability of DaVita HealthCare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DaVita HealthCare's price. Additionally, you may evaluate how the addition of DaVita HealthCare to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |